ALLO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Allogene Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.735 USD 0.29%

Market Cap: $598.8m

	Allogene Therapeutics Inc NASDAQ:ALLO	US
S	Swire Properties Ltd F:SW9	HK
P	Pushpay Holdings Ltd OTC:PHPYF	NZ
	CJ Corp KRX:001040	KR

Profitability Summary

Allogene Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2.893%

Negative 3Y Average Operating Margin

-390.183%

Operating Margin is Increasing

-188.658% > -2.893%

Negative Net Margin

-2.648%

Negative 3Y Average Net Margin

-393.226%

Net Margin is Increasing

-186.679% > -2.648%

Negative Free Cash Flow Margin

-2.211%

Negative 3Y Average Free Cash Flow Margin

-250.517%

Free Cash Flow Margin is Increasing

-127.095% > -2.211%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-140%

ROIC is Increasing

-100% > -66%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.